VB Spine Receives FDA Clearance for Expanded Vitoss Indications
NEW YORK, July 29, 2026 VB Spine LLC announced that the U.S. Food and Drug Administration (FDA) has granted...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NEW YORK, July 29, 2026 VB Spine LLC announced that the U.S. Food and Drug Administration (FDA) has granted...
Seoul, South Korea | April 24, 2025 CGBIO has achieved a major regulatory milestone with the U.S. Food and...
Westminster, Colorado | April 24, 2026 Cerapedics has announced a strategic supplier agreement with Vizient, significantly expanding access to...
